Page last updated: 2024-11-05

xylazine and Cardiotoxicity

xylazine has been researched along with Cardiotoxicity in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polegato, BF1
Minicucci, MF1
Azevedo, PS1
Carvalho, RF1
Chiuso-Minicucci, F1
Pereira, EJ1
Paiva, SA1
Zornoff, LA1
Okoshi, MP1
Matsubara, BB1
Matsubara, LS1

Other Studies

1 other study available for xylazine and Cardiotoxicity

ArticleYear
Acute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in rats.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:5

    Topics: Animals; Blood Pressure; Cardiotoxicity; Doxorubicin; Echocardiography; Heart; Intercellular Adhesio

2015